Poly Medicure

Aging Populations And Medtech Trends Will Unlock Global Potential

AnalystHighTarget

Not Invested

Community Contributor

Published

17 Aug 25

AnalystHighTarget's Fair Value

₹2,841.99

32.7% undervalued

10 Sep

₹1,912.00

-18.4%

-2.0%

-18.4%

-2.0%

You can edit this narrative until Aug 17 9:31 PM. Then, changes will post as Updates.

Author's Valuation

₹2.84k32.7% undervalued

AnalystHighTarget Fair Value

Narrative

Updates0

AnalystHighTarget Fair Value

₹2.84k

32.7% undervalued

Future estimation in

% p.a.

Decrease

Increase

Current revenue growth rate

16.40%

Medical Equipment revenue growth rate

0.43%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

13.71%

Calculation

₹5.95b

Earnings '28

80.80x

PE Ratio '28

₹481.04b

Market Cap '28

₹481.04b

Market Cap '28

115.09m

No. shares '28

₹4.18k

Share Price '28

₹4.18k Share Price '28

Discounted to 2025 @ 13.75% p.a.

₹2.84k

Fair Value '25